Discover 1,378 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
St. Louis currently offers medical research opportunities for a variety of conditions, including cancer, heart disease, prurigo nodularis, and pain management. The city's leading institutions are actively recruiting participants, offering opportunities for healthy volunteers in paid studies, as well as those seeking trials for specific health conditions, providing access to innovative treatments and advanced medical care.
Filter
2
Filter results
Results: 1,378
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
for
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Location: St Louis MO, Kansas City KS, Ann Arbor MI, Rock Hill SC,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT07088926
Phase2, Recruiting
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Location: St Louis MO, Cleveland OH, Durham NC, Fairfax VA,
Sponsor: Plexium, Inc.
Sex: All
Age: 18+
Code: NCT07284186
Phase1, Recruiting
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
for
Multiple Sclerosis
Location: St Louis MO, Milwaukee WI, Washington D.C. DC,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 60
Code: NCT07224373
Phase1, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Location: St Louis MO, Kansas City MO, Nashville TN, Niles IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07431281
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: St Louis MO, Hazelwood MO, City of Saint Peters MO,
Sponsor: Kallyope Inc.
Sex: All
Age: 18 - 70+
Code: NCT07645924
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
for
Rheumatoid Arthritis
Location: St Louis MO, Willowbrook IL, Windsor, Lake Charles LA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07276581
Phase2, Recruiting
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
for
ER+ HER2- Advanced Breast Cancer,
Location: St Louis MO, Nashville TN, Houston TX, Providence RI
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06188520
Phase1, Phase2, Recruiting
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
for
Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer,
Location: St Louis MO, Pittsburgh PA, Charlotte NC, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05123482
Phase1, Phase2, Recruiting
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
for
Hepatocellular Carcinoma
Location: St Louis MO, Houston TX, Los Angeles CA
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06795022
Phase1, Phase2, Recruiting
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
for
Proteinuric Kidney Disease
Location: St Louis MO, City of Saint Peters MO, Bowling Green KY,
Sponsor: Maze Therapeutics
Sex: All
Age: 18 - 68
Code: NCT06830629
Phase2, Recruiting
Study of AZD0754 in Participants With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: St Louis MO, Atlanta GA, Houston TX, Philadelphia PA,
Sponsor: AstraZeneca
Sex: Male
Age: 18 - 70+
Code: NCT06267729
Phase1, Phase2, Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for
Non-Small Cell Lung Cancer
Location: St Louis MO, Carterville IL, Jonesboro AR,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT06767514
Phase3, Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
for
Plasma Cell Myeloma Refractory
Location: St Louis MO, Kansas City MO, Nashville TN,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06356571
Phase2, Recruiting
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
for
Excessive Sleepiness, Shift-work Disorder
Location: St Louis MO, Chesterfield MO, Chicago IL,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06568367
Phase3, Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Location: St Louis MO, Indianapolis IN, Kansas City MO,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06465810
Recruiting
JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
for
Solid Tumors
Location: St Louis MO, Nashville TN, Cleveland OH, Houston TX,
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Sex: All
Age: 18+
Code: NCT06386146
Phase1, Phase2, Recruiting
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
for
Biliary Tract Cancer
Location: St Louis MO, Kansas City MO, Chicago IL, Niles IL,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06467357
Phase3, Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: St Louis MO, Louisville KY, Nashville TN, Niles IL,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase3, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: St Louis MO, Louisville KY, Hinsdale IL, Chicago IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase3, Recruiting
Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
for
Hereditary Angioedema (HAE)
Location: St Louis MO, Wheaton IL, Little Rock AR, Milwaukee WI,